Development of Fully Human, Bispecific Antibodies that Effectively Block Omicron Variant Pseudovirus Infections
J. K. Allen, M. A. Gonzalez, J. Kaur, M. Smith, J. You, G. Yang, D. Zha, Z. Tian, A. Al-Shami, C. Shi, J. J. Molldrem, T. Heffernan
This study develops fully human bispecific antibodies that effectively block Omicron variant pseudovirus infections, showing improved neutralization compared to monoclonal antibodies.
bioRxiv · Mar 7, 2023 · PreprintBiochemistry